iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 370.4% in August

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 38,100 shares, a growth of 370.4% from the August 15th total of 8,100 shares. Based on an average daily trading volume, of 24,800 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.7% of the shares of the stock are sold short. Currently, 0.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 24,800 shares, the days-to-cover ratio is presently 1.5 days.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in IDNA. Cambridge Investment Research Advisors Inc. raised its holdings in iShares Genomics Immunology and Healthcare ETF by 4.0% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 19,797 shares of the company’s stock worth $406,000 after purchasing an additional 756 shares during the last quarter. Flow Traders U.S. LLC bought a new stake in iShares Genomics Immunology and Healthcare ETF during the 2nd quarter worth about $931,000. Ameriprise Financial Inc. raised its holdings in iShares Genomics Immunology and Healthcare ETF by 23.6% during the 4th quarter. Ameriprise Financial Inc. now owns 71,832 shares of the company’s stock worth $1,626,000 after purchasing an additional 13,721 shares during the last quarter. Finally, Portland Global Advisors LLC bought a new stake in iShares Genomics Immunology and Healthcare ETF during the 2nd quarter worth about $2,099,000.

iShares Genomics Immunology and Healthcare ETF Stock Down 2.3%

iShares Genomics Immunology and Healthcare ETF stock opened at $22.65 on Friday. The stock has a 50-day simple moving average of $21.99 and a 200 day simple moving average of $21.04. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $17.26 and a 12-month high of $25.80. The stock has a market capitalization of $116.65 million, a price-to-earnings ratio of 14.76 and a beta of 0.90.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.